Related Experiment Videos
Genetic toxicity of dopamine
Abstract:
The genetic toxicity of dopamine was studied in a battery of test systems including DNA single-strand break analysis in cultured human skin fibroblasts, the Salmonella/mammalian-microsome mutagenicity test, sister-chromatid exchange analysis in human lymphocytes, the mouse-lymphoma forward mutation assay, the sex-linked recessive lethal test in Drosophila melanogaster and the micronucleus test in mouse and rat. Dopamine at concentrations of 50-300 micrograms/ml induced DNA strand breaks in human fibroblasts. It also gave a positive response in the mouse-lymphoma forward mutation assay, where a dose-dependent increase in the frequency of mutant cells was observed in the presence of dopamine, 94-750 micrograms/ml. All other tests showed no response to dopamine. The dopamine-induced DNA strand breaks in human fibroblasts were inhibited by superoxide dismutase or dithiothreitol. Furthermore, dopamine caused nicking of circular Col El DNA and bound to calf thymus DNA in vitro. It is suggested that this genetic activity of dopamine in vitro relates to oxidation of dopamine and the generation of reactive oxygen radicals, semiquinones and quinones. It is unlikely that similar reactions would occur and cause genotoxic activity of dopamine in vivo.
Insights
Dopamine induced DNA strand breaks and mutations in specific lab tests. However, these genetic toxicity effects in vitro are likely due to oxidation and unlikely to occur in living organisms.
Area of Science:
- Biochemistry
- Genetics
- Toxicology
Background:
- Dopamine is a crucial neurotransmitter involved in various physiological processes.
- Understanding the potential genotoxicity of dopamine is important for assessing its safety.
Purpose of the Study:
- To evaluate the genetic toxicity of dopamine using a comprehensive battery of in vitro and in vivo assays.
- To investigate the mechanisms underlying any observed genotoxic effects.
Main Methods:
- DNA single-strand break analysis in human fibroblasts.
- Salmonella/mammalian-microsome mutagenicity test.
- Sister-chromatid exchange analysis in human lymphocytes.
- Mouse-lymphoma forward mutation assay.
- Sex-linked recessive lethal test in Drosophila melanogaster.
- Micronucleus test in mice and rats.
- In vitro DNA nicking and binding assays.
Main Results:
- Dopamine induced DNA strand breaks in human fibroblasts at concentrations of 50-300 µg/ml.
- Dopamine showed a dose-dependent increase in mutations in the mouse-lymphoma forward mutation assay (94-750 µg/ml).
- DNA strand breaks were inhibited by superoxide dismutase or dithiothreitol, suggesting a role for reactive oxygen species.
- Dopamine caused DNA nicking and bound to DNA in vitro.
- All other tested systems (bacterial mutagenicity, SCE, Drosophila, micronucleus) showed no response.
Conclusions:
- Dopamine exhibits genotoxic activity in vitro, specifically inducing DNA strand breaks and mutations.
- The in vitro genotoxicity is likely mediated by dopamine oxidation and the generation of reactive oxygen species, semiquinones, and quinones.
- It is unlikely that these genotoxic mechanisms would operate in vivo, suggesting dopamine is not genotoxic in living organisms under normal conditions.